Episodios

  • Key Clinical Characteristics of IgA Nephropathy to Apply in Practice
    Jul 16 2024

    Dive into the fascinating world of immunoglobulin A nephropathy (IgAN), the most common form of primary glomerulonephritis worldwide.

    Credit available for this activity expires: 7/16/25
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001351?ecd=bdc_podcast_libsyn_mscpedu

    Más Menos
    34 m
  • Building Confidence in Care: Strategies to Address Vaccine Hesitancy in Hispanic Communities
    Jul 12 2024

    Are you providing culturally competent care for your Hispanic patients?

    Credit available for this activity expires: 7/12/25
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001327?ecd=bdc_podcast_libsyn_mscpedu

    Más Menos
    24 m
  • Navigating Relapsed/Refractory CLL/SLL Together: Where Disease-, Treatment-, and Patient-Centered Care Unite
    Jul 9 2024

    Did you know 59% of patients value doctors asking about their information needs and desired level of care involvement? Join us to explore these and other insights in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL).

    Credit available for this activity expires: 7/5/25
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001303?ecd=bdc_podcast_libsyn_mscpedu

    Más Menos
    1 h y 14 m
  • Navigating Patient-Centered Care of CLL and MCL: Empowering Collaboration and Communication
    Jun 28 2024

    Are you aware of the DREAM protocol that can facilitate a 2-way exchange between patients and clinicians?

    Credit available for this activity expires: 6/28/2025
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001200?ecd=bdc_podcast_libsyn_mscpedu

    Más Menos
    52 m
  • Unmasking Cognitive Impairment and Negative Symptoms in Schizophrenia
    Jun 27 2024

    Short on time? You can still screen for these function-limiting symptoms.

    Credit available for this activity expires: 6/26/25
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001208?ecd=bdc_podcast_libsyn_mscpedu

    Más Menos
    38 m
  • What's on the Horizon in Atopic Dermatitis? A Focus on OX40-OX40 Ligand-Targeted Therapies
    Jun 26 2024

    Did you know that targeting the OX40-OX40 ligand (OX40-OX40L) pathway may lead to long-term remission in atopic dermatitis (AD)?

    Credit available for this activity expires: 6/26/25
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001214?ecd=bdc_podcast_libsyn_mscpedu

    Más Menos
    29 m
  • Expert Opinions on Treating Metabolic Dysfunction-Associated Steatohepatitis
    Jun 26 2024

    How would you manage a patient with metabolic syndrome and metabolic dysfunction-associated steatohepatitis?

    Credit available for this activity expires: 6/26/25
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001260?ecd=bdc_podcast_libsyn_mscpedu

    Más Menos
    17 m
  • Connecting With the Experts at ASCO 2024: Clinical Pearls and Data Insights About Anti-HER2 Therapies in Biliary Tract Cancer
    Jun 25 2024

    Get the latest data from ASCO 2024 about anti-HER2 therapies in biliary tract cancer.

    Credit available for this activity expires: 6/25/25
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001250?ecd=bdc_podcast_libsyn_mscpedu

    Más Menos
    24 m